Decibel Therapeutics is a hearing company focused on discovering and developing new medicines to protect, repair and restore hearing. By combining recent innovations in hearing science with leading diagnostic tools, biological insights, modeling and therapeutic delivery techniques, Decibel is pioneering a comprehensive approach to define the underlying biological causes of hearing loss and develop a pipeline of breakthrough drugs targeted to specific indications and patients.

Contact Information

215 First St
Cambridge, MA 02142
United States

Overview

Total FundingEmployeesLast Funding DateStatus
$107,000,00011-502018-06-19Operating

Crunchbase Investment Rounds

DateAmountRoundValuationLead InvestorOther Investors
2018-06-19$55,000,000Series CBessemer Venture Partners, Schroder Adveq, Foresite Capital, GV, Third Rock Ventures, The Longevity Fund, SR One
2015-10-15$52,000,000Series AThird Rock VenturesGlaxoSmithKline, SR One